Abstract. The effect of media conditioned by concanavalin A-activated spleen cells (C-sup) on insulin release and its islet cell cytotoxicity were studied. In a functional study, C-sup significantly inhibited both basal insulin release and glucose-stimulated insulin release. Morphologically, C-sup had a destructive effect on isolated islets after 72h incubation. Islet cell cytotoxicity was shown by lactate dehydrogenase (LDH) release assay after 5 days incubation with C-sup in a dose-dependent manner. These results suggest that acceleration of the onset of diabetes in young diabetes prone (DP) Bio-Breeding/Worcester (BB/W) rats following the injection of C-sup may depend on the suppressive and cytotoxic effects of C-sup on pancreatic islet cells. (Endocrinol Japon 38: 47-52, 1991) 
THE BB rat develops diabetes similar to human insulin-dependent diabetes mellitus (IDDM) [1, 2] . Approximately 50% of DP rats spontaneously develop diabetes between 60 and 120 days of age, while less than 0.5% of DP rats become diabetic before 60 days of age. An autoimmune pathogenesis of BB rat diabetes is thought to be due to the infiltration of mononuclear cells into the islets of Langerhans (insulitis) [3] and to the presence of circulating autoantibodies to pancreatic islets [4] . The disease is prevented by immunosuppression [5] , thymectomy [1] , bone marrow allografts [6, 7] and lymphocyte transfusion [8] . Concanavalin A (Con A) activated spleen cells from acutely diabetic BB rats adoptively transfer diabetes to young naive DP rats and non-diabetic Wistar Furth rats [9] . Furthermore, C-sup from acutely diabetic DP or non-diabetic rats accelerates the appearance of diabetes in young DP or diabetes resistant (DR) rats [10] .
To investigate the mechanism of this acceleration, we studied the cytotoxic effect of C-sup on pancreatic islets and the effect of C-sup on insulin release in vitro. Our very subtle morphological changes, so these islets were also used for the insulin release study.
Insulin release and insulin concentration of islet Insulin release was studied in quadruplicated groups of 10 islets. During the first hour of incubation, islets were cultured in Krebs Ringer Bicarbonate (KRB) solution containing 5.6mM glucose, 20mM Hepes (Wako, Tokyo), 0.5% bovine serum albumin (Seikagaku Kogyo Co., Tokyo) and 2.5 mM CaCl2. The medium was then gently removed and replaced by another KRB solution containing 16.7mM glucose and incubation was continued for a further 1 h. The insulin concentration in the medium was measured by radioimmunoassay (Dainabot Co., Ltd, Tokyo). Islets used for the insulin release experiment were ultrasonically disrupted in acid/ethanol for the assay of the insulin concentration in the islets. Basal insulin release at 5.6mM glucose in KRB solution was slightly lower in the precultured group with C-sup (20-fold dilution) than in the control group but the difference was not signi-16.7mM glucose was significantly lower in the precultured group than in the control group (P<0.05). Total insulin release from precultured islets was 84% of that from control islets. The insulin concentration in precultured islets also decreased significantly in comparison with control islets (P<0.05).
These data suggest that C-sup might inhibit not only insulin release but also insulin synthesis (Fig. 2) . [ 12] , and macrophages or peritoneal exudate cells from BB/W rats also had a cytotoxic effect on the rat islet cells or rat insulinoma cell line [ 13] . Second, the cytotoxic T cells from NOD mouse destroyed mouse islet cells in a MHC restricted manner [14] . In addition to these cell mediated cytotoxicities, it was also reported that crude IL-1 and several kinds of recombinant cytokines affect the function or mortality of rat and mouse islets [15] [16] [17] , and also combined treatment with IFN-y, TNF, lymphotoxin and IL-1 results in a synergistic cytotoxic effect on islet cells [18, 19] . Adoptive transfer of diabetes was successfully performed by the transfusion of Con A-activated spleen cells from acutely diabetic DP BB/W rats to young (less than 60 day old) DP rats or immunosuppressed non-diabetic Wistar Furth (WF) rats [20] . It was therefore assumed that cell-mediated cytotoxicity is important in inducing autoimmune diabetes. In addition to these reports, it has also been reported that C-sup accelerated the onset of diabetes in young DP rats and induced diabetes in young DR BB/W rats but failed to induce diabetes in other non-diabetic WF rats. Since 1% of DR rats become spontaneously diabetic and the depletion of RT6-positive lymphocytes could induce diabetes in 50% of DR rats [21] , it was suggested that an inactive effector cell population may be present in DR rats. From these observations it was concluded that the activation of the native effector cell population in DP or DR rats by C-sup is more likely to be the mechanism that kills pancreatic islet cells than the direct cytotoxic effect of C-sup. However, it is difficult to maintain a certain concentration of C-sup in pancreatic islets, because the injection was done once a day and a high concentration bolus injection of C-sup could have a fatal side effect. Consequently, the direct effect of C-sup on pancreatic islets following in vivo administration still remains unclear.
In this experiment, we found cytotoxic activity of C-sup against islet cell monolayers, and IL-1 accounted for the most of this activity. Furthermore, IL-1 seemed to have a synergistic cytotoxic effect with other lymphokines on pancreatic islet cells. Although Con A itself is a lymphotrophic factor, unconditioned medium which contained only Con A failed to lyse the target cells. Therefore, the cytotoxicity of C-sup cannot be explained by Con A itself.
Since our present study clearly showed that C-sup showed remarkable islet cell cytotoxicity in vitro, we believe that C-sup could play an important role in accelerating the onset of diabetes when combined with the cytotoxicity of native effector cells in vivo.
Moreover, we also found that C-sup had an inhibitory effect on basal insulin release and glucose-stimulated insulin release. The inhibitory effect of C-sup was found not only in insulin release but also in insulin synthesis. These effects could be an another factor which contributes to the acceleration of the onset of diabetes.
In summary, we conclude that the direct effect of C-sup, which has a high titer of IL-1 activity, may play an important role in accelerating the onset of diabetes in young DP or DR rats.
